Susan Orr
Director/Miembro de la Junta en OPTHEA LIMITED .
Fortuna: - $ al 31/05/2024
Origen de la red de primer grado Susan Orr.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel.
3
| Holding Company | Medical/Nursing Services | 3 |
Retina Global
1
| Private Company | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Susan Orr a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CELGENE | Biotechnology | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Corporate Officer/Principal Corporate Officer/Principal | |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VIVUS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| Simon Fraser University | College/University | Masters Business Admin | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree | |
| The University of Newcastle | College/University | Chief Tech/Sci/R&D Officer | |
| Queensland University of Technology | College/University | Doctorate Degree | |
| Instituto de Empresa SL | College/University | Masters Business Admin | |
| Swinburne University of Technology | College/University | Undergraduate Degree | |
Vegenics Pty Ltd.
 Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million. | Medical/Nursing Services | Corporate Secretary | |
The Schepens Eye Research Institute, Inc.
 The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Medical/Nursing Services | Corporate Officer/Principal | |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chairman Corporate Officer/Principal | |
CPA Australia Ltd.
 CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Roche Group Pty Ltd. | Corporate Officer/Principal | ||
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman | |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Opthea Pty Ltd. | Chief Executive Officer | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Victor Smorgon Group
 Victor Smorgon Group Oil Refining/MarketingEnergy Minerals The Victor Smorgon Group is a private family office that focuses on building generational wealth. The private company is based in South Yarra, Australia. The Australian company has a long history of building wealth for over four generations, starting from humble beginnings. The company offers specialist investment services that provide unique and exciting investment opportunities to its extensive networks. The company was founded in 1995 by Peter Edwards, who has been the CEO since 1995. | Oil Refining/Marketing | Director of Finance/CFO | |
| ENLITIC, INC. | Packaged Software | Chief Executive Officer Chairman | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
| GALENICA AG | Medical Distributors | Director/Board Member | |
| Vectorlab GmbH | Chairman | ||
| INVEX THERAPEUTICS LTD | Biotechnology | Director/Board Member | |
Safar Partners LLC
 Safar Partners LLC Investment ManagersFinance Safar Partners LLC (Safar Partners) is a venture capital firm founded in 2019 by Nader Motamedy. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
GelMEDIX, Inc.
 GelMEDIX, Inc. Miscellaneous Commercial ServicesCommercial Services GelMEDIX, Inc. operates as a biotechnology technology. The company is headquartered in Newton, MA. | Miscellaneous Commercial Services | Founder | |
Aramis Biosciences, Inc.
 Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Pharmaceuticals: Major | Founder | |
| Kera Therapeutics, Inc. | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 29 |
| Australia | 15 |
| Canadá | 3 |
| Suiza | 3 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Health Services | 3 |
| Retail Trade | 2 |
Operativa
| Director/Board Member | 133 |
| Corporate Officer/Principal | 70 |
| Independent Dir/Board Member | 42 |
| Chief Executive Officer | 27 |
| Chairman | 22 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Adrienne Graves | 38 |
| Marc M. P. de Garidel | 32 |
| Dan Spiegelman | 25 |
| Julia Haller | 22 |
| Timothy Morris | 21 |
| Jeremy Levin | 18 |
| Lawrence Gozlan | 13 |
| Anshul Thakral | 13 |
| Kenneth Harrison | 13 |
| Judith Robertson | 12 |
| Reza Dana | 11 |
| Michael Sistenich | 10 |
| Joel Naor | 10 |
| Frédéric Guerard | 10 |
| Julie Clark | 9 |
- Bolsa de valores
- Insiders
- Susan Orr
- Conexiones Empresas
